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S U M M A R Y
A retrospective analysis of patients diagnosed with tetanus was conducted to evaluate the occurrence of
Guillain–Barre´ syndrome (GBS). Two of 13 tetanus cases were complicated with GBS. Their symptoms
and signs related to GBS improved markedly after a 5-day infusion of intravenous immunoglobulin.
Physicians should keep in mind that GBS can be an important cause of muscle weakness in patients with
tetanus.
 2016 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Although its cause is unknown, Guillain–Barre´ Syndrome (GBS)
is thought to be an autoimmune process triggered by antigenic
stimulation,1 resulting in demyelination and destruction of the
peripheral nerves. There is evidence against an association of GBS
with tetanus toxoid-containing vaccine,2 but the association of
GBS with tetanus is unknown. A retrospective analysis of patients
diagnosed with tetanus who were admitted to Wonkwang
University Hospital in South Korea between January 2000 and
December 2015 was conducted to examine the occurrence of GBS.Table 1
Characteristics of tetanus patients with Guillain–Barre´ syndrome
Case 1 
Age, years 71 
Sex Male 
Type of tetanus Generalized 
Identiﬁable portal of entry Lower limb 
Severity of tetanus Severe 
Time from onset of tetanus to GBS (days) 23 
Duration of ICU stay after onset of GBS (days) 22 
Previous use of drugs affecting muscle strength Magnesium sulfate, diazepa
Symptoms and signs at an early stage of GBS
Muscle strength from MRC grading MRC grade 1 in lower limb
Deep tendon reﬂex Not noticed 
NCS ﬁndings 1. Diffuse sensory-motor po
with absent or delayed F
2. Mainly demyelinating ty
axonopathy
Therapeutic option for GBS IVIG for 5 days 
Muscle strength after infusion of IVIG MRC grade 4 in lower limb
GBS, Guillain–Barre´ syndrome; ICU, intensive care unit; IVIG, intravenous immunoglob
http://dx.doi.org/10.1016/j.ijid.2016.04.011
1201-9712/ 2016 The Author(s). Published by Elsevier Ltd on behalf of International S
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).2. Patients
During the study period, 13 patients were diagnosed with
generalized tetanus. The mean age of these patients was 63.5
(range 38–79) years, and 62% (8/13) were men. The treatments for
tetanus included metronidazole (100%, 13/13), tetanus immune
globulin (92.3%, 12/13), a benzodiazepine such as midazolam or
diazepam (92.3%, 12/13), muscle relaxants (69.2%, 9/13), and
wound care (61.5%, 8/13). Eleven patients (84.6%) underwent
airway management (six endotracheal intubations and ﬁve
tracheostomies). Ten patients (76.9%) were admitted into theCase 2
79
Female
Generalized
Neck
Severe
8
6
m Vecuronium, midazolam
s MRC grade 2 in all limbs
Diminished
lyneuropathy
 waves in the limbs
pe with secondary
1. Diffuse motor dominant polyneuropathy with
absent F waves in the limbs
2. Mainly demyelinating type with secondary
axonopathy
3. Delayed terminal latencies in the right phrenic
nerve
IVIG for 5 days
s MRC grade 4 in all limbs
ulin; MRC, Medical Research Council; NCS, nerve conduction study.
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range of 3–30 days). One patient (7.7%) died of tetanus. One or
more complications of tetanus were observed in 11 patients
(84.6%): 10 patients (76.9%) with autonomic dysfunction, eight
(61.5%) with hospital-acquired infections (eight pneumonia, three
wound infections, and three Clostridium difﬁcile infections), and
one (7.7%) with deep vein thrombosis.
During the study period, two cases (15.4%) were complicated
with GBS. Before they were diagnosed with GBS, one patient
received midazolam and vecuronium, and the other patient
received diazepam and magnesium sulfate. Despite discontinuing
these drugs based on the improvement in the tetanus, the patients
had muscle weakness of the limbs and abnormal deep tendon
reﬂex responses. The results of nerve conduction studies (NCS)
were strongly suggestive of GBS. For both patients, their symptoms
and NCS ﬁndings fulﬁlled the requirements for level 2 of the
Brighton criteria for GBS.3 Because sampling of cerebrospinal ﬂuid
had not been performed, cytoalbuminological dissociations could
not be conﬁrmed. The GBS occurred 23 days after the onset of
tetanus in one patient (case 1) and 8 days after onset in the other
patient (case 2). After a 5-day infusion of intravenous immuno-
globulin, muscle strength improved in both patients, from Medical
Research Council (MRC) grade 1 to MRC grade 4 or higher (Table 1).
3. Discussion
The patients with tetanus investigated in this study received
diverse drugs including sedatives, muscle relaxants, and magne-
sium sulfate to relieve the tetanus-related symptoms, and these
could lead to generalized muscle weakness. A tracheostomy was
performed in some patients with tetanus, and these patients were
admitted to the ICU for mechanical ventilation.4 It is well known
that a substantial number of patients admitted to the ICU will
develop ICU-acquired weakness (ICUAW).5 In the present study,
when a physician detected muscle weakness in a patient, the
physician surmised that the muscle weakness may have resulted
from the drugs prescribed or ICUAW. However, in some cases,
muscle weakness continued after these drugs were discontinued,
and the patients were ﬁnally diagnosed with GBS based on the
symptoms and the results of NCS testing. Thus generalized tetanus
can be complicated with GBS. Therefore, the physician should keepin mind that GBS could be an important cause of muscle weakness
in patients with tetanus.
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